MACK

Merrimack Pharmaceuticals, Inc.

Delisted

MACK was delisted on the 17th of May, 2024.

62 hedge funds and large institutions have $98.5M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.38M
Puts
$407K
Net Calls
Net Calls Change

Top Buyers

1 +$5.58M
2 +$1.52M
3 +$1.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.21M
5
Northern Trust
Northern Trust
Illinois
+$1.08M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23M
2
$20.6M
3
$8.32M
4
$6.85M
5
$6.8M
6
$5.66M
7
$3.62M
8
$3.58M
9
$3M
10
$2.52M
11
$2.14M
12
$1.43M
13
$1.37M
14
$1.23M
15
$1.13M
16
$1.07M
17
$1.02M
18
$905K
19
$789K
20
$571K
21
$421K
22
$364K
23
$177K
24
$174K
25
$169K